Quantum
Home > Boards > Stock Clubs > Market Trends and Strategies > Franklin, Andrews, Kramer & Edelstein (DWP)

Trading Suspensions: 34-61603 Mar. 1, 2010 PrimeGen Energy

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
scion Member Profile
Member Level 
Followed By 229
Posts 46,930
Boards Moderated 14
Alias Born 04/12/01
160x600 placeholder
scion Member Level  Monday, 03/01/10 11:24:54 AM
Re: None
Post # of 33311 
Trading Suspensions: 34-61603 Mar. 1, 2010 PrimeGen Energy Corporation
http://www.sec.gov/litigation/suspensions/2010/34-61603.pdf

See also Order
http://www.sec.gov/litigation/suspensions/2010/34-61603-o.pdf

http://www.sec.gov/litigation/suspensions.shtml

SECURITIES EXCHANGE ACT OF 1934 RELEASE NO. 61603 / March 1, 2010

SEC SUSPENDS TRADING IN THE SECURITIES OF PRIMEGEN ENERGY CORPORATION

The Securities and Exchange Commission (the “SEC”) today announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the “Exchange Act”), of trading in the securities of PrimeGen Energy Corporation, a company organized under the laws of Nevada, commencing at 9:30 a.m. EST on March 1, 2010, and terminating at 11:59 p.m. EST on March 12, 2010.

The Commission temporarily suspended trading in the securities of PrimeGen because of questions that have arisen regarding the adequacy and accuracy of publicly disseminated information concerning, among other things, PrimeGen’s current financial condition, management, and business operations, and the promotion of PrimeGen’s stock. PrimeGen is quoted on the Pink Sheets under the symbol “PGNE.”

The Commission cautions brokers, dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the companies.

Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the rule. If any broker or dealer has any questions as to whether or not it has complied with the rule, it should not enter any quotation but immediately contact the staff in the Division of Trading and Markets, Office of Interpretation and Guidance, at (202) 5515760. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, it should refrain from entering quotations relating to PrimeGen’s securities until such time as it has familiarized itself with the rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation that is in violation of the rule, the Commission will consider the need for prompt enforcement action.

The SEC’s Office of Investor Education and Advocacy has information for investors and members of the general public on topics directly related to this action by the SEC. See http://www.sec.gov/investor/antispaminitiative.htm for a compilation of helpful links


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist